Prostate-specific antigen (PSA) and digital rectal examination followed by transrectal ultrasound (TRUS)–guided biopsies are the standard approaches in the primary assessment of prostate cancer [1]. The gene discussed is KLK3; the disease is Familial prostate cancer.